• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症免疫疗法治疗转移瘤:过去、现在与未来。

Cancer immunotherapy for metastasis: past, present and future.

机构信息

Department of Orthopaedics, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Second Road, Guangzhou, P.R. China.

Department of Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.

出版信息

Brief Funct Genomics. 2019 Mar 22;18(2):140-146. doi: 10.1093/bfgp/ely022.

DOI:10.1093/bfgp/ely022
PMID:29992233
Abstract

Cancer is a complex and refractory disease, which can disseminate from primary site to a different site even at an early stage. Cancer immunotherapy harnesses host immune system to battle against cancer, but only a minority of patients benefit from it. Genetic-based technologies have significantly promoted the development of cancer immunotherapy. Here we describe genetic-based cancer immunotherapies in three aspects: recombinant cancer vaccine, immune checkpoint blockade therapy and adoptive cell transfer. In the future, multi-disciplinary collaboration will greatly increase the scope and effectiveness of cancer immunotherpy.

摘要

癌症是一种复杂且难治的疾病,即使在早期阶段,也可能从原发部位扩散到其他部位。癌症免疫疗法利用宿主免疫系统来对抗癌症,但只有少数患者从中受益。基于基因的技术极大地促进了癌症免疫疗法的发展。在这里,我们从三个方面描述了基于基因的癌症免疫疗法:重组癌症疫苗、免疫检查点阻断疗法和过继细胞转移。在未来,多学科合作将极大地增加癌症免疫疗法的范围和效果。

相似文献

1
Cancer immunotherapy for metastasis: past, present and future.癌症免疫疗法治疗转移瘤:过去、现在与未来。
Brief Funct Genomics. 2019 Mar 22;18(2):140-146. doi: 10.1093/bfgp/ely022.
2
Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.当前和未来新型免疫疗法在泌尿肿瘤学中的应用:文献综述的批判性评价。
Eur Urol Focus. 2018 Apr;4(3):442-454. doi: 10.1016/j.euf.2017.10.001. Epub 2017 Oct 19.
3
Immunotherapy as an Option for Cancer Treatment.免疫疗法作为癌症治疗的一种选择。
Arch Immunol Ther Exp (Warsz). 2018 Apr;66(2):89-96. doi: 10.1007/s00005-017-0491-5. Epub 2017 Oct 12.
4
Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.解决伊朗的癌症免疫疗法研究问题:过继细胞疗法即将面世。
Cytotherapy. 2018 Oct;20(10):1227-1237. doi: 10.1016/j.jcyt.2018.08.002. Epub 2018 Sep 26.
5
Recent advances in cancer immunotherapy with an emphasis on vaccines.癌症免疫疗法的最新进展,重点是疫苗。
Expert Rev Vaccines. 2009 Jan;8(1):25-8. doi: 10.1586/14760584.8.1.25.
6
Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.用于癌症免疫治疗的纳米、微米和宏观药物输送系统。
Acta Biomater. 2019 Feb;85:1-26. doi: 10.1016/j.actbio.2018.12.028. Epub 2018 Dec 19.
7
Emerging immunotherapies for glioblastoma.胶质母细胞瘤的新兴免疫疗法。
Expert Opin Emerg Drugs. 2016 Jun;21(2):133-45. doi: 10.1080/14728214.2016.1186643.
8
A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.癌症患者治疗性疫苗接种的范式转变:在预防环境中应用治疗性疫苗接种策略的必要性。
Immunol Rev. 2008 Apr;222:316-27. doi: 10.1111/j.1600-065X.2008.00605.x.
9
An overview of cancer immunotherapeutic strategies.癌症免疫治疗策略概述。
Immunotherapy. 2018 Aug;10(11):999-1010. doi: 10.2217/imt-2018-0002.
10
Emerging immunotherapy for the treatment of esophageal cancer.用于治疗食管癌的新兴免疫疗法。
Expert Opin Investig Drugs. 2016 Jun;25(6):667-77. doi: 10.1517/13543784.2016.1163336. Epub 2016 Mar 24.

引用本文的文献

1
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.基于肽的药物研发进展:递送平台、治疗药物与疫苗
Signal Transduct Target Ther. 2025 Mar 5;10(1):74. doi: 10.1038/s41392-024-02107-5.
2
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II-IVa esophageal cancer: a network meta-analysis.新辅助免疫疗法联合化疗治疗II-IVa期食管癌的疗效与安全性:一项网状Meta分析
Syst Rev. 2025 Jan 27;14(1):26. doi: 10.1186/s13643-025-02765-8.
3
Nanotechnology-Based Strategies for Safe and Effective Immunotherapy.
基于纳米技术的安全有效免疫治疗策略
Molecules. 2024 Dec 11;29(24):5855. doi: 10.3390/molecules29245855.
4
Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review.探索成簇规律间隔短回文重复序列-CRISPR相关蛋白9(CRISPR-Cas9)作为癌症治疗手段的研究:一项范围综述
Cureus. 2024 Jul 11;16(7):e64324. doi: 10.7759/cureus.64324. eCollection 2024 Jul.
5
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience.西米普利单抗作为晚期阴茎鳞状细胞癌的一线治疗:真实世界经验
J Pers Med. 2023 Nov 20;13(11):1623. doi: 10.3390/jpm13111623.
6
Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer.泛癌症分析和实验验证确定 ndc1 为胰腺癌潜在的免疫、预后和治疗生物标志物。
Aging (Albany NY). 2023 Sep 20;15(18):9779-9796. doi: 10.18632/aging.205048.
7
Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis.免疫疗法治疗晚期或转移性食管鳞癌患者的疗效和安全性比较:系统评价和网络荟萃分析。
BMC Cancer. 2022 Sep 17;22(1):992. doi: 10.1186/s12885-022-10086-5.
8
Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer.铁死亡相关长链非编码RNA作为卵巢癌的预后生物标志物
Front Oncol. 2022 Jun 9;12:888699. doi: 10.3389/fonc.2022.888699. eCollection 2022.
9
Metastasis prevention: targeting causes and roots.转移预防:针对病因和根源。
Clin Exp Metastasis. 2022 Aug;39(4):505-519. doi: 10.1007/s10585-022-10162-x. Epub 2022 Mar 26.
10
An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer.基于自然杀伤细胞的联合免疫疗法和病毒疗法的交互式补充生物杂交系统用于癌症治疗。
Adv Sci (Weinh). 2022 Jan;9(2):e2103470. doi: 10.1002/advs.202103470. Epub 2021 Nov 7.